Overexpression of ARF1 is associated with cell proliferation and migration through PI3K signal pathway in ovarian cancer.(adenosine diphosphate ribosylation fator; and phosphoinositide 3-kinase)
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Oncology reports - 37(2017), 3, Seite 1511 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhong, Jianxin [VerfasserIn] |
|---|
| Themen: |
Care and treatment |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1995323470 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1995323470 | ||
| 003 | DE-627 | ||
| 005 | 20230514091049.0 | ||
| 007 | tu | ||
| 008 | 170721s2017 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a PQ20170721 |
| 035 | |a (DE-627)OLC1995323470 | ||
| 035 | |a (DE-599)GBVOLC1995323470 | ||
| 035 | |a (PRQ)g915-58533397c65d308a5c70047a1cb5c444f101bd7af2fab9d1de5ec447d9d476120 | ||
| 035 | |a (KEY)0246155220170000037000301511overexpressionofarf1isassociatedwithcellproliferat | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ZDB |
| 100 | 1 | |a Zhong, Jianxin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Overexpression of ARF1 is associated with cell proliferation and migration through PI3K signal pathway in ovarian cancer.(adenosine diphosphate ribosylation fator; and phosphoinositide 3-kinase) |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 540 | |a Nutzungsrecht: © COPYRIGHT 2017 Spandidos Publications | ||
| 650 | 4 | |a Gene expression | |
| 650 | 4 | |a G proteins | |
| 650 | 4 | |a Ovarian cancer | |
| 650 | 4 | |a Health aspects | |
| 650 | 4 | |a Development and progression | |
| 650 | 4 | |a Care and treatment | |
| 650 | 4 | |a Genetic aspects | |
| 700 | 1 | |a Chen, Yannan |4 oth | |
| 700 | 1 | |a Chen, Jie |4 oth | |
| 700 | 1 | |a Jin, Yunfeng |4 oth | |
| 700 | 1 | |a Zhou, Linsen |4 oth | |
| 700 | 1 | |a Cheng, Jialin |4 oth | |
| 700 | 1 | |a Xi, Qinghxja |4 oth | |
| 700 | 1 | |a Duan, Chengwei |4 oth | |
| 700 | 1 | |a Chen, Caiwen |4 oth | |
| 700 | 1 | |a Gu, Guifang |4 oth | |
| 700 | 1 | |a Shi, Nannan |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Oncology reports |d Athens : Nat. Hellenic Research Foundation, 1994 |g 37(2017), 3, Seite 1511 |w (DE-627)18263907X |w (DE-600)1222484-4 |w (DE-576)049953168 |x 1021-335X |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2017 |g number:3 |g pages:1511 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 37 |j 2017 |e 3 |h 1511 | ||